Retrospective Assessment of a Serum Proteomic Test in a Phase III Study Comparing Erlotinib plus Placebo with Erlotinib plus Tivantinib (MARQUEE) in Previously Treated Patients with Advanced Non‐Small Cell Lung Cancer

BACKGROUND. The VeriStrat test provides accurate predictions of outcomes in all lines of therapy for patients with non‐small cell lung cancer (NSCLC). We investigated the predictive and prognostic role of VeriStrat in patients enrolled on the MARQUEE phase III trial of tivantinib plus erlotinib (T+E...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Buttigliero, Consuelo, Shepherd, Frances A., Barlesi, Fabrice, Schwartz, Brian, Orlov, Sergey, Favaretto, Adolfo G., Santoro, Armando, Hirsh, Vera, Ramlau, Rodryg, Blackler, Adele R., Roder, Joanna, Spigel, David, Novello, Silvia, Akerley, Wallace, Scagliotti, Giorgio V.
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley & Sons, Inc. 2018
Assuntos:
European Perspectives
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656491/
https://ncbi.nlm.nih.gov/pubmed/30139835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0089
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados